LLY vs STEM · P/E 39, rev $65.18B vs rev $144.6M
Eli Lilly and Company (LLY) versus Stem Inc (STEM) — a side-by-side from cached financials, not a winner call.
Eli Lilly and Company (LLY) is a drug manufacturers - general company listed on NYSE. It is led by David Ricks.
Stem Inc (STEM) is a utilities - renewable company listed on US.
Latest reported LLY revenue for 2025-12-31 was $65.18B. Net income was $20.64B. Revenue was up 44.7% from 2024-12-31 to 2025-12-31. LLY currently screens at market cap $991.62B and trailing P/E 39.5.
Latest reported STEM revenue for 2024-12-31 was $144.6M. Net income was -$854.0M. Revenue was down 68.7% from 2023-12-31 to 2024-12-31. STEM currently screens at market cap $82.1M.
LLY currently screens at market cap $991.62B and trailing P/E 39.5. STEM currently screens at market cap $82.1M.
Not investment advice. Open the LLY and STEM stock pages for the full models.
Not investment advice.